10 reports

THESE INCLUDE IMMUNOTHERAPIES, ANTIBODY-DRUG CONJUGATES (ADCS), BISPECIFIC T-CELL ENGAGER (BITE) ANTIBODIES (ABS) AND MONOCLONAL ABS (MABS).

  • Immunotherapy
  • Protein Therapy
  • Vaccine
  • Market Size
  • Sanofi S.A.

THESE INCLUDE IMMUNOTHERAPIES, ANTIBODY-DRUG CONJUGATES (ADCS), BISPECIFIC T-CELL ENGAGER (BITE) ANTIBODIES (ABS) AND MONOCLONAL ABS (MABS).

  • Immunotherapy
  • Monoclonal Antibody
  • Vaccine
  • Market Size
  • Sanofi S.A.
  • PLATFORMS

ADVAXIS IMMUNOTHERAPIES ##.

  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Ablynx NV
  • Sanofi S.A.

DURING CHILDHOOD, ASTHMA IS MORE COMMON IN MALES, WITH A MALE-TO-FEMALE RATIO OF ##:## UP TO PUBERTY, WHEN IT CHANGES TO ##:##.

  • Immunotherapy
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Sanofi S.A.

Immunotherapies account for only nine therapy products.

  • Clinical Trial
  • Dementia
  • Immunotherapy
  • Therapy
  • Sanofi S.A.

Efficacy and safety of emerging immunotherapies in psoriasis.

  • Autoimmune Disease
  • Immunology
  • Immunotherapy
  • Therapy
  • Sanofi S.A.

From tool to therapy: a timeline of monoclonal antibody technology.

  • Immunotherapy
  • Medical Biotechnology
  • Monoclonal Antibody
  • AbbVie Inc.
  • Sanofi S.A.

DARWIN ## ##. ##. ##. ##. ##.

  • Arthritis
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Sanofi S.A.

RORg Agonists as a Novel Immunotherapy Approach for Cancer Annual Meeting of the American Association for Cancer Research (AACR); Philadelphia, PA, USA; Apr ## - ##, 2015a: abstract ## and Poster Hu X, Moisan J, Majchrzak K et al.

  • Immunotherapy
  • Pharmaceutical
  • 4SC Discovery GmbH
  • Advinus
  • Sanofi S.A.

The prominent features of this report are - ##.

  • Clinical Trial
  • Encephalitis
  • Immunotherapy
  • Neurology
  • Sanofi S.A.